ReviewBiomedicines2025

STING-Activating Nanoparticles Combined with PD-1/PD-L1 Blockade: A Synergistic Approach in Cancer Immunotherapy.

Dorota Bartusik-Aebisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.